| CID 9916412 | IC50 | 0.18 [1] |
| N-[(1R)-6-[(Tert-butylamino)methyl]-1,2,3,4-tetrahydronaphthalen-1-yl]-2-[(2S)-1-[3-(trifluoromethyl)phenyl]sulfonylpiperidin-2-yl]acetamide | IC50 | 13.0 [1], 23.0 [2] |
| N-[(1R)-6-[(Tert-butylamino)methyl]-1,2,3,4-tetrahydronaphthalen-1-yl]-2-[(2S)-1-[3-(trifluoromethyl)phenyl]sulfonylpiperidin-2-yl]acetamide | Ki | 23.0 [1] |
| Methyl 2-chloro-6-[3-fluoro-4-[(1R)-1-[[1-[(2,2,2-trifluoroacetyl)amino]cyclopropanecarbonyl]amino]ethyl]phenyl]benzoate | IC50 | 1.52 [1] |
| Methyl 2-chloro-6-[3-fluoro-4-[(1R)-1-[[1-[(2,2,2-trifluoroacetyl)amino]cyclopropanecarbonyl]amino]ethyl]phenyl]benzoate | Ki | 0.44 [1], 2.0 [2] |
| 2-[(2R)-1-(4-Methylphenyl)sulfonyl-3-oxopiperazin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | IC50 | 0.22 [1] |
| 2-[(2R)-1-(4-Methylphenyl)sulfonyl-3-oxopiperazin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | Ki | 0.1 [1], 0.16 [2] |
| Chroman 28 | IC50 | 0.4 [1], 3.4 [2] |
| Chroman 28 | Ki | 0.7 [1], 0.77 [2] |
| Methyl 2-fluoro-6-[3-fluoro-4-[[[5-(4-pyridin-2-ylpiperazine-1-carbonyl)pyridin-2-yl]amino]methyl]phenyl]benzoate | Ki | 65.0 [1], 85.0 [2], 286.0 [3], 726.0 [4], 10000.0 [5] |
| (3R)-3-(4-Fluorophenyl)-N-[(4R)-7-(piperidin-1-ylmethyl)-3,4-dihydro-2H-chromen-4-yl]-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]propanamide | IC50 | 0.8 [1] |
| (3R)-3-(4-Fluorophenyl)-N-[(4R)-7-(piperidin-1-ylmethyl)-3,4-dihydro-2H-chromen-4-yl]-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]propanamide | Ki | 0.4 [1] |
| 1-[(3R)-2-Oxo-5-(2-phenylethyl)-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-pyridin-4-ylpiperazin-1-yl)phenyl]urea | IC50 | 1.9 [1] |
| 1-[(3R)-2-Oxo-5-(2-phenylethyl)-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-pyridin-4-ylpiperazin-1-yl)phenyl]urea | Ki | 0.59 [1] |
| (3R)-3-(Naphthalen-2-ylsulfonylamino)-3-phenyl-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]propanamide | IC50 | 5.5 [1] |
| (3R)-3-(Naphthalen-2-ylsulfonylamino)-3-phenyl-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]propanamide | Ki | 0.24 [1] |
| (2R)-N-[(1R)-1-[5-[5-Chloro-3-fluoro-2-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-3-fluoropyridin-2-yl]ethyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide | IC50 | 4.47 [1] |
| (2R)-N-[(1R)-1-[5-[5-Chloro-3-fluoro-2-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-3-fluoropyridin-2-yl]ethyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide | Ki | 0.5 [1], 0.66 [2], 1.85 [3] |
| N-[(2-Chlorophenyl)methyl]-2-[[3-methoxy-4-(2-methylpropoxy)phenyl]methyl-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]sulfonylamino]acetamide | Ki | 11.0 [1], 37.0 [2] |
| 2-[(2R)-1-(3,4-Dichlorophenyl)sulfonyl-3-oxo-2,4-dihydroquinoxalin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | IC50 | 0.55 [1] |
| 2-[(2R)-1-(3,4-Dichlorophenyl)sulfonyl-3-oxo-2,4-dihydroquinoxalin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | Ki | 0.1 [1] |
| N-[(1R)-6-(Aminomethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]-2-[(2R)-1-(4-methylphenyl)sulfonyl-3-oxopiperazin-2-yl]acetamide | IC50 | 238.0 [1] |
| N-[(1R)-6-(Aminomethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]-2-[(2R)-1-(4-methylphenyl)sulfonyl-3-oxopiperazin-2-yl]acetamide | Ki | 60.0 [1] |
| Nvp-saa164 | IC50 | 33.0 [1] |
| Nvp-saa164 | Ki | 8.0 [1], 10.0 [2] |
| Methyl 2-[4-[[[3-(3,3,3-trifluoropropanoylamino)pyridin-2-yl]amino]methyl]phenyl]benzoate | Ki | 11.8 [1], 12.0 [2] |
| N-[2-[4-(4,5-Dihydro-1H-imidazol-2-yl)phenyl]ethyl]-2-[(2R)-1-naphthalen-2-ylsulfonyl-3-oxo-2,4-dihydroquinoxalin-2-yl]acetamide | IC50 | 0.04 [1] |
| N-[2-[4-(4,5-Dihydro-1H-imidazol-2-yl)phenyl]ethyl]-2-[(2R)-1-naphthalen-2-ylsulfonyl-3-oxo-2,4-dihydroquinoxalin-2-yl]acetamide | Ki | 0.02 [1] |
| (2R,3S)-2,3-Dihydroxy-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-[3-(trifluoromethyl)phenyl]sulfonylbutanamide | IC50 | 4.3 [1] |
| (2R,3S)-2,3-Dihydroxy-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-[3-(trifluoromethyl)phenyl]sulfonylbutanamide | Ki | 4.1 [1] |
| 2-[(2R)-1-(4-Methylphenyl)sulfonyl-3-oxo-2,4-dihydroquinoxalin-2-yl]-N-[(4R)-7-(piperidin-1-ylmethyl)-3,4-dihydro-2H-chromen-4-yl]acetamide | IC50 | 0.14 [1] |
| 2-[(2R)-1-(4-Methylphenyl)sulfonyl-3-oxo-2,4-dihydroquinoxalin-2-yl]-N-[(4R)-7-(piperidin-1-ylmethyl)-3,4-dihydro-2H-chromen-4-yl]acetamide | Ki | 0.24 [1] |
| 3-(4-Oxochromen-3-yl)-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]benzamide | IC50 | 112.0 [1] |
| 3-(4-Oxochromen-3-yl)-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]benzamide | Ki | 64.0 [1] |
| 3-(4-Methyl-1-oxophthalazin-2-yl)-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]benzamide | IC50 | 3405.0 [1] |
| 3-(4-Methyl-1-oxophthalazin-2-yl)-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]benzamide | Ki | 6366.0 [1] |
| Kallidin, des-Arg(10)- | IC50 | 0.87 [1] |
| Kallidin, des-Arg(10)- | Ki | 0.2 [1] |
| Fasitibant | Ki | 10000.0 [1] |
| Safotibant | Ki | 0.3 [1], 0.35 [2] |
| Methyl 2-fluoro-6-[3-fluoro-4-[[[1-[(2,2,2-trifluoroacetyl)amino]cyclopropanecarbonyl]amino]methyl]phenyl]benzoate | Ki | 1.47 [1], 1.5 [2] |
| N-[1-[4-[(2S)-2-Amino-6-(dimethylamino)hexanoyl]piperazin-1-yl]-2-methyl-1-oxopropan-2-yl]-2,4-dichloro-3-[(2,4-dimethylquinolin-8-yl)oxymethyl]benzenesulfonamide | Ki | 5.5 [1], 10000.0 [2] |
| N-[1-[4-[(2S)-2-Amino-5-(dimethylamino)pentanoyl]piperazin-1-yl]-2-methyl-1-oxopropan-2-yl]-2,4-dichloro-3-[(2,4-dimethylquinolin-8-yl)oxymethyl]benzenesulfonamide | Ki | 5.5 [1], 10000.0 [2] |
| N-[1-[4-[(3S)-3-Amino-6-(dimethylamino)hexanoyl]piperazin-1-yl]-2-methyl-1-oxopropan-2-yl]-2,4-dichloro-3-[(2,4-dimethylquinolin-8-yl)oxymethyl]benzenesulfonamide | Ki | 5.5 [1], 10000.0 [2] |
| Methyl 2-[4-[[[2-methyl-2-(3,3,3-trifluoropropanoylamino)propanoyl]amino]methyl]phenyl]benzoate | Ki | 3450.0 [1], 3500.0 [2] |
| Methyl 2-[4-[[[1-(3,3,3-trifluoropropanoylamino)cyclopropanecarbonyl]amino]methyl]phenyl]benzoate | Ki | 63.0 [1] |
| Methyl 2,4-dichloro-6-[3-fluoro-4-[(1R)-1-[[1-[(2,2,2-trifluoroacetyl)amino]cyclopropanecarbonyl]amino]ethyl]phenyl]benzoate | Ki | 0.4 [1], 0.46 [2] |
| 4-Bromo-3-[(2-chlorobenzoyl)amino]-N-[2-(1-pyridin-4-ylpiperidin-4-yl)ethyl]-1H-pyrazole-5-carboxamide | IC50 | 3.0 [1], 3.5 [2] |
| Tetrahydrofuran-2-ylmethyl 4-{[(2-benzoylphenyl)amino]sulfonyl}phenylcarbamate | Ki | 0.7 [1] |
| N-(2-Benzoyl-phenyl)-4-[3-(3-piperidin-1-yl-propyl)-ureido]-benzenesulfonamide | Ki | 0.25 [1] |
| N-[4-(2-Benzoyl-phenylsulfamoyl)-phenyl]-acetamide | Ki | 45.0 [1] |
| Methyl 2-[4-[[[3-(pentanoylamino)pyridin-2-yl]amino]methyl]phenyl]benzoate | Ki | 200.0 [1] |
| Methyl 2-fluoro-6-[3-fluoro-4-[(pyridin-2-ylamino)methyl]phenyl]benzoate | Ki | 815.0 [1] |
| (2R)-N-[3-[(4-Carbamimidoylbenzoyl)amino]propyl]-1-[2,4-dichloro-3-[(2,4-dimethylquinolin-8-yl)oxymethyl]phenyl]sulfonylpyrrolidine-2-carboxamide | Ki | 5.5 [1], 10000.0 [2] |
| Unii-8PY38jsg1Y | Ki | 0.02 [1] |
| Methyl 2-fluoro-6-[3-fluoro-4-[(1R)-1-[[1-[(2,2,2-trifluoroacetyl)amino]cyclopropanecarbonyl]amino]ethyl]phenyl]benzoate | IC50 | 1.9 [1] |
| Methyl 2-fluoro-6-[3-fluoro-4-[(1R)-1-[[1-[(2,2,2-trifluoroacetyl)amino]cyclopropanecarbonyl]amino]ethyl]phenyl]benzoate | Ki | 0.57 [1] |
| 1-(5-Cyclohexyl-2-oxo-1-propyl-3H-1,4-benzodiazepin-3-yl)-3-[4-[4-(dimethylamino)piperidin-1-yl]phenyl]urea | IC50 | 164.0 [1] |
| 1-(5-Cyclohexyl-2-oxo-1-propyl-3H-1,4-benzodiazepin-3-yl)-3-[4-[4-(dimethylamino)piperidin-1-yl]phenyl]urea | Ki | 28.0 [1] |
| N-[(1R)-1-[2-Fluoro-4-[3-fluoro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]phenyl]ethyl]-1-[(2,2,2-trifluoroacetyl)amino]cyclopropane-1-carboxamide | IC50 | 0.89 [1] |
| N-[(1R)-1-[2-Fluoro-4-[3-fluoro-2-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]phenyl]ethyl]-1-[(2,2,2-trifluoroacetyl)amino]cyclopropane-1-carboxamide | Ki | 0.51 [1] |
| N-[(1R)-1-[2-Fluoro-4-[3-fluoro-2-(2-methyltetrazol-5-yl)phenyl]phenyl]ethyl]-1-[(2,2,2-trifluoroacetyl)amino]cyclopropane-1-carboxamide | IC50 | 0.65 [1] |
| N-[(1R)-1-[2-Fluoro-4-[3-fluoro-2-(2-methyltetrazol-5-yl)phenyl]phenyl]ethyl]-1-[(2,2,2-trifluoroacetyl)amino]cyclopropane-1-carboxamide | Ki | 0.6 [1] |
| 1-[(3S)-5-Cyclohexyl-2-oxo-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-piperidin-1-ylpiperidin-1-yl)phenyl]urea | IC50 | 2200.0 [1] |
| 1-[(3S)-5-Cyclohexyl-2-oxo-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-piperidin-1-ylpiperidin-1-yl)phenyl]urea | Ki | 1023.0 [1] |
| 1-[(3R)-5-Cyclohexyl-2-oxo-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-pyridin-4-ylpiperazin-1-yl)phenyl]urea | IC50 | 8.0 [1] |
| 1-[(3R)-5-Cyclohexyl-2-oxo-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-pyridin-4-ylpiperazin-1-yl)phenyl]urea | Ki | 1.33 [1] |
| 1-[(3R)-5-(4-Methylphenyl)-2-oxo-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-piperidin-1-ylpiperidin-1-yl)phenyl]urea | IC50 | 64.5 [1] |
| 1-[(3R)-5-(4-Methylphenyl)-2-oxo-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-piperidin-1-ylpiperidin-1-yl)phenyl]urea | Ki | 13.4 [1] |
| 1-[(3R)-2-Oxo-5-(2-phenylethyl)-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-piperidin-1-ylpiperidin-1-yl)phenyl]urea | IC50 | 4.83 [1] |
| 1-[(3R)-2-Oxo-5-(2-phenylethyl)-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-piperidin-1-ylpiperidin-1-yl)phenyl]urea | Ki | 1.37 [1] |
| 1-[(3R)-5-Cyclohexyl-2-oxo-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-piperidin-1-ylpiperidin-1-yl)phenyl]urea | IC50 | 24.7 [1] |
| 1-[(3R)-5-Cyclohexyl-2-oxo-1-propyl-3H-1,4-benzodiazepin-3-yl]-3-[4-(4-piperidin-1-ylpiperidin-1-yl)phenyl]urea | Ki | 5.73 [1] |
| Methyl 4-chloro-2-[4-[(1R)-1-[[4-chloro-3-[(2-cyanoacetyl)amino]pyridin-2-yl]amino]ethyl]phenyl]benzoate | IC50 | 1.5 [1] |
| Methyl 4-chloro-2-[4-[(1R)-1-[[4-chloro-3-[(2-cyanoacetyl)amino]pyridin-2-yl]amino]ethyl]phenyl]benzoate | Ki | 0.8 [1] |
| 2-[1-(2-Chlorophenyl)sulfonyl-3-oxopiperazin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | IC50 | 0.55 [1] |
| 2-[1-(2-Chlorophenyl)sulfonyl-3-oxopiperazin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | Ki | 0.41 [1] |
| N-[(1R)-6-[(Cyclopropylmethylamino)methyl]-1,2,3,4-tetrahydronaphthalen-1-yl]-2-[(2S)-1-[3-(trifluoromethyl)phenyl]sulfonylpiperidin-2-yl]acetamide | IC50 | 16.0 [1], 31.0 [2] |
| N-[(1R)-6-[(Tert-butylamino)methyl]-1,2,3,4-tetrahydronaphthalen-1-yl]-2-[(2S)-1-[4-methyl-3-(trifluoromethyl)phenyl]sulfonylpiperidin-2-yl]acetamide | IC50 | 11.0 [1], 16.0 [2] |
| 2-[1-(4-Methylphenyl)sulfonyl-3-oxopiperazin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | IC50 | 0.3 [1] |
| 2-[1-(4-Methylphenyl)sulfonyl-3-oxopiperazin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | Ki | 0.3 [1] |
| N-[(1R)-6-[(Propan-2-ylamino)methyl]-1,2,3,4-tetrahydronaphthalen-1-yl]-2-[(2S)-1-[3-(trifluoromethyl)phenyl]sulfonylpiperidin-2-yl]acetamide | IC50 | 72.0 [1], 110.0 [2] |
| N-[(1R)-6-[(2-Methylpropylamino)methyl]-1,2,3,4-tetrahydronaphthalen-1-yl]-2-[(2S)-1-[3-(trifluoromethyl)phenyl]sulfonylpiperidin-2-yl]acetamide | IC50 | 13.0 [1], 42.0 [2] |
| 2-[3-Oxo-1-[3-(trifluoromethyl)phenyl]sulfonylpiperazin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | IC50 | 0.94 [1] |
| 2-[3-Oxo-1-[3-(trifluoromethyl)phenyl]sulfonylpiperazin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | Ki | 0.15 [1] |
| 2-[1-[(5-Chloro-1-benzothiophen-2-yl)sulfonyl]-3-oxopiperazin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | IC50 | 3.3 [1] |
| 2-[1-[(5-Chloro-1-benzothiophen-2-yl)sulfonyl]-3-oxopiperazin-2-yl]-N-[(1R)-6-(piperidin-1-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | Ki | 0.1 [1] |
| (3R)-N-[(4R)-1-Methyl-2,2-dioxo-7-(piperidin-1-ylmethyl)-3,4-dihydro-2lambda6,1-benzothiazin-4-yl]-3-(naphthalen-2-ylsulfonylamino)-3-phenylpropanamide | IC50 | 10.7 [1] |
| (3R)-N-[(4R)-1-Methyl-2,2-dioxo-7-(piperidin-1-ylmethyl)-3,4-dihydro-2lambda6,1-benzothiazin-4-yl]-3-(naphthalen-2-ylsulfonylamino)-3-phenylpropanamide | Ki | 1.3 [1] |
| 4-Bromo-5-[(2-chlorobenzoyl)amino]-N-[2-(4-pyridinyl)ethyl]-1H-pyrazole-3-carboxamide | IC50 | 490.0 [1] |
| 4-Bromo-5-[(2-chlorobenzoyl)amino]-N-[2-(4-pyridinyl)ethyl]-1H-pyrazole-3-carboxamide | Ki | 120.0 [1] |
| N-[4-Chloro-2-[[(1R)-1-[4-[3-fluoro-2-(2-methyltetrazol-5-yl)phenyl]phenyl]ethyl]amino]pyridin-3-yl]-2-cyanoacetamide | IC50 | 1.17 [1] |
| N-[4-Chloro-2-[[(1R)-1-[4-[3-fluoro-2-(2-methyltetrazol-5-yl)phenyl]phenyl]ethyl]amino]pyridin-3-yl]-2-cyanoacetamide | Ki | 0.5 [1] |
| N-[(1R)-6-[(Cyclobutylamino)methyl]-1,2,3,4-tetrahydronaphthalen-1-yl]-2-[(2S)-1-[3-(trifluoromethyl)phenyl]sulfonylpiperidin-2-yl]acetamide | IC50 | 54.0 [1], 58.0 [2] |
| 2-[(2R)-1-(4-Methylphenyl)sulfonyl-3-oxopiperazin-2-yl]-N-[(1R)-6-(morpholin-4-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | IC50 | 1.2 [1] |
| 2-[(2R)-1-(4-Methylphenyl)sulfonyl-3-oxopiperazin-2-yl]-N-[(1R)-6-(morpholin-4-ylmethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | Ki | 3.0 [1] |
| 4-(Benzhydryl-amino)-N,N-bis-(3-dimethylamino-propyl)-3-nitro-benzenesulfonamide | IC50 | 6200.0 [1] |
| 4-(Benzhydryl-amino)-N,N-bis-(3-dimethylamino-propyl)-3-nitro-benzenesulfonamide | Ki | 3000.0 [1] |
| 2-[(2R)-1-(4-Methylphenyl)sulfonyl-3-oxopiperazin-2-yl]-N-[(1R)-6-[(4-methylpiperazin-1-yl)methyl]-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide | IC50 | 1.46 [1] |